Reported Sep 29, 2021 · Terminated
Naproxen Sodium Tablets, USP 275 mg 100 Tablets Rx Only NDC 68462-178-01 Manufactured by: Glenmark Pharmaceuticals…
Glenmark Pharmaceuticals Inc., USA
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Glenmark Pharmaceuticals Inc., USA · 750 Corporate Dr · Mahwah, NJ · 07430-2009
Is this the product you have?
- Naproxen Sodium Tablets, USP 275 mg 100 Tablets Rx
- Only NDC 68462-178-01 Manufactured byGlenmark Pharmaceuticals Inc., USA 4147 Goldmine Road Monroe
- NC 28110 Manufactured forGlenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430
- Lot codes and dates
- Lots
29190087 Exp. 10/31/202129190088 Exp. 10/31/202129190089 Exp. 10/31/202129200077 Exp. 11/30/202229200078 Exo11/30/2022
- Lots
- Amount recalled
- 9552 bottles
This recall covers 8 products
The agency filed one notice per product. You are reading one of them; the other 7 are below.
Where it was sold
- Nationwide
Why it was recalled
CGMP Deviations
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Glenmark Pharmaceuticals Inc., USA recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.